Literature DB >> 15169899

FERM domain interaction promotes FAK signaling.

Jill M Dunty1, Veronica Gabarra-Niecko, Michelle L King, Derek F J Ceccarelli, Michael J Eck, Michael D Schaller.   

Abstract

From the results of deletion analyses, the FERM domain of FAK has been proposed to inhibit enzymatic activity and repress FAK signaling. We have identified a sequence in the FERM domain that is important for FAK signaling in vivo. Point mutations in this sequence had little effect upon catalytic activity in vitro. However, the mutant exhibits reduced tyrosine phosphorylation and dramatically reduced Src family kinase binding. Further, the abilities of the mutant to transduce biochemical signals and to promote cell migration were severely impaired. The results implicate a FERM domain interaction in cell adhesion-dependent activation of FAK and downstream signaling. We also show that the purified FERM domain of FAK interacts with full-length FAK in vitro, and mutation of this sequence disrupts the interaction. These findings are discussed in the context of models of FAK regulation by its FERM domain.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15169899      PMCID: PMC419890          DOI: 10.1128/MCB.24.12.5353-5368.2004

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  60 in total

1.  A region encompassing the FERM domain of Jak1 is necessary for binding to the cytokine receptor gp130.

Authors:  C M Hilkens; H Is'harc; B F Lillemeier; B Strobl; P A Bates; I Behrmann; I M Kerr
Journal:  FEBS Lett       Date:  2001-09-07       Impact factor: 4.124

2.  Unexpected effects of FERM domain mutations on catalytic activity of Jak3: structural implication for Janus kinases.

Authors:  Y J Zhou; M Chen; N A Cusack; L H Kimmel; K S Magnuson; J G Boyd; W Lin; J L Roberts; A Lengi; R H Buckley; R L Geahlen; F Candotti; M Gadina; P S Changelian; J J O'Shea
Journal:  Mol Cell       Date:  2001-11       Impact factor: 17.970

3.  Structural basis for neurofibromatosis type 2. Crystal structure of the merlin FERM domain.

Authors:  Toshiyuki Shimizu; Azusa Seto; Nobuo Maita; Keisuke Hamada; Shoichiro Tsukita; Sachiko Tsukita; Toshio Hakoshima
Journal:  J Biol Chem       Date:  2001-12-27       Impact factor: 5.157

4.  SRC catalytic but not scaffolding function is needed for integrin-regulated tyrosine phosphorylation, cell migration, and cell spreading.

Authors:  Leslie A Cary; Richard A Klinghoffer; Christoph Sachsenmaier; Jonathan A Cooper
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

Review 5.  Biochemical signals and biological responses elicited by the focal adhesion kinase.

Authors:  M D Schaller
Journal:  Biochim Biophys Acta       Date:  2001-07-25

6.  The structural basis of localization and signaling by the focal adhesion targeting domain.

Authors:  Stefan T Arold; Maria K Hoellerer; Martin E M Noble
Journal:  Structure       Date:  2002-03       Impact factor: 5.006

7.  Src mediates stimulation by vascular endothelial growth factor of the phosphorylation of focal adhesion kinase at tyrosine 861, and migration and anti-apoptosis in endothelial cells.

Authors:  R Abu-Ghazaleh; J Kabir; H Jia; M Lobo; I Zachary
Journal:  Biochem J       Date:  2001-11-15       Impact factor: 3.857

8.  The focal adhesion targeting (FAT) region of focal adhesion kinase is a four-helix bundle that binds paxillin.

Authors:  Ikuko Hayashi; Kristiina Vuori; Robert C Liddington
Journal:  Nat Struct Biol       Date:  2002-02

9.  Structural insight into the mechanisms of targeting and signaling of focal adhesion kinase.

Authors:  Gaohua Liu; Cristina D Guibao; Jie Zheng
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

10.  Src-mediated coupling of focal adhesion kinase to integrin alpha(v)beta5 in vascular endothelial growth factor signaling.

Authors:  Brian P Eliceiri; Xose S Puente; John D Hood; Dwayne G Stupack; David D Schlaepfer; Xiaozhu Z Huang; Dean Sheppard; David A Cheresh
Journal:  J Cell Biol       Date:  2002-04-01       Impact factor: 10.539

View more
  44 in total

1.  Conformational dynamics of the focal adhesion targeting domain control specific functions of focal adhesion kinase in cells.

Authors:  Gress Kadaré; Nicolas Gervasi; Karen Brami-Cherrier; Heike Blockus; Said El Messari; Stefan T Arold; Jean-Antoine Girault
Journal:  J Biol Chem       Date:  2014-11-12       Impact factor: 5.157

Review 2.  Focal adhesion kinase-related protein tyrosine kinase Pyk2 in T-cell activation and function.

Authors:  Hanne L Ostergaard; Tara L Lysechko
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

3.  The tyrosine kinase pyk2 promotes migration and invasion of glioma cells.

Authors:  Christopher A Lipinski; Nhan L Tran; Emmanuel Menashi; Carole Rohl; Jean Kloss; R Curtis Bay; Michael E Berens; Joseph C Loftus
Journal:  Neoplasia       Date:  2005-05       Impact factor: 5.715

4.  A FAK/Src chimera with gain-of-function properties promotes formation of large peripheral adhesions associated with dynamic actin assembly.

Authors:  Priscila M F Siesser; Leslie M Meenderink; Larisa Ryzhova; Kristin E Michael; David W Dumbauld; Andrés J García; Irina Kaverina; Steven K Hanks
Journal:  Cell Motil Cytoskeleton       Date:  2008-01

5.  Focal Adhesion Kinase: The Reversible Molecular Mechanosensor.

Authors:  Samuel Bell; Eugene M Terentjev
Journal:  Biophys J       Date:  2017-06-06       Impact factor: 4.033

6.  Structural basis for the autoinhibition of focal adhesion kinase.

Authors:  Daniel Lietha; Xinming Cai; Derek F J Ceccarelli; Yiqun Li; Michael D Schaller; Michael J Eck
Journal:  Cell       Date:  2007-06-15       Impact factor: 41.582

7.  AMPA receptors promote perivascular glioma invasion via beta1 integrin-dependent adhesion to the extracellular matrix.

Authors:  Yuji Piao; Li Lu; John de Groot
Journal:  Neuro Oncol       Date:  2008-10-28       Impact factor: 12.300

8.  Structural conservation in band 4.1, ezrin, radixin, moesin (FERM) domains as a guide to identify inhibitors of the proline-rich tyrosine kinase 2.

Authors:  Nathalie Meurice; Lei Wang; Christopher A Lipinski; Zhongbo Yang; Christopher Hulme; Joseph C Loftus
Journal:  J Med Chem       Date:  2010-01-28       Impact factor: 7.446

Review 9.  FERM control of FAK function: implications for cancer therapy.

Authors:  Ssang-Taek Lim; David Mikolon; Dwayne G Stupack; David D Schlaepfer
Journal:  Cell Cycle       Date:  2008-05-29       Impact factor: 4.534

10.  Functional characterization of KIN-32, the Caenorhabditis elegans homolog of focal adhesion kinase.

Authors:  Erin J Cram; Kristina Marie Fontanez; Jean E Schwarzbauer
Journal:  Dev Dyn       Date:  2008-03       Impact factor: 3.780

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.